Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Topotecan and Intravenous Paclitaxel in Advanced NSCLC and Other Solid Tumors
NCT00004979Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topotecan in non-small cell lung cancer (NSCLC), solid tumor, sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: completed.
02
Drugs
topotecan
03
Conditions
non-small cell lung cancer (NSCLC)solid tumor
Beyond the preview
Go deeper on NCT00004979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004979.